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Neuronal growth inhibitory factor (GIF), also known as metallothionein (metallothionein-3), impairs the survival and neurite
formation of cultured neurons. It is known that the α-β domain-domain interaction of hGIF is crucial to the neuron growth
inhibitory bioactivity although the exact mechanism is not clear. Herein, the β(MT3)-β(MT3) mutant and the hGIF-truncated
Δ33-35 mutant were constructed, and their biochemical properties were characterized by pH titration, EDTA, and DTNB
reactions. Their inhibitory activity toward neuron survival and neurite extension was also examined. We found that the Δ33-
35 mutant α-domain containing β-domain-like M3S9 cluster exhibits the function of α-domain with M4S11 cluster in hGIF. These
resultsshowedthatthestabilityandsolventaccessibilityofthemetal-thiolateclusterinβ-domainisverysigniﬁcanttotheneuronal
growth inhibitory activity of hGIF and also indicated that the particular primary structure of α-domain is pivotal to domain-
domain interaction in hGIF.
1.Introduction
The pathological pattern of Alzheimer’s disease (AD) is
characterizedbytheprogressivelossofneuronsaccompanied
by the formation of intraneural neuroﬁbrillary tangles and
extracellular amyloid plaques [1]. One hypothesis postu-
lated that these symptoms are caused by an imbalance of
neurotrophic factors [2]. In 1988, Uchida and coworkers
established that brain extracts from AD patients stimulate
the neuron survival to a greater degree than normal brain
extracts, due to the loss of a human growth inhibitory
factor (hGIF) [3, 4]. It has also been reported that the
metallothionein-3 (MT3) level decreases in astrocytes in
lesioned areas of degenerative diseases such as Parkin-
son’s disease, amyothrophic lateral sclerosis, and progressive
supranuclear palsy [5]. Because of the high homogeneity
in primary structure with MT1/MT2, hGIF was classiﬁed
as a member of MT family and was also named hMT3
[6].
Metallothioneins (MTs) are low molecular weight, cys-
teinerich, and metal ion binding proteins. In mammalians,
four MT isoforms (MT1, MT2, MT3, and MT4) have been
identiﬁed [7] .T h et w om a j o ri s o f o r m sM T 1a n dM T 2a r e
found in most organs and can be rapidly induced by a
wide range of stimuli, such as metal ions and cytokines
[8, 9]. However, MT3 and MT4 are speciﬁcally expressed in
the central nervous system (CNS) and stratiﬁed squamous
epithelia,respectively,andhavenoresponsetotheseinducers
[7]. All of the mammalian MTs display two domains,
and each domain contains a metal-thiolate cluster: the
N-terminal β-domain contains a cluster of three metals
coordinated with nine cysteines; the C-terminal α-domain
contains a cluster of four metals coordinated with eleven
cysteines. The cluster structure, where the metal ions are
tetrahedrallycoordinatedbybridgingandterminalcysteines,
is important for the function of MTs [10]. Unlike most
other metalloproteins, metallothionein can bind metals with
a high thermodynamic stability [11–13]. These properties2 Bioinorganic Chemistry and Applications
are believed to enable MTs also to function in essential
trace metal homeostasis, detoxiﬁcation of heavy metal ions
and oxidative stress response [14, 15], and so forth. Despite
the high similarities between the primary structures of MT-3
and mammalian MT-1/MT-2, the biological properties of
these three proteins diﬀer. The most conspicuous feature is
that MT-3 but not MT-1/MT-2 exhibits a neuron growth
inhibitory activity in neuronal cell culture studies. This
activity of MT-3 has been reported for the native Cu4Zn3-
hGIF and recombinant Zn7-hGIF [16]. Further studies have
established that the inhibitory activity is mainly related
to the N-terminal β-domain, whereas the C-terminal α-
domain alone is found to be inactive [17, 18]. According
to our previous studies, it is indicated that the neuronal
growthinhibitorybioactivityofhMT3isregulatedbyvarious
factors.Forexamples,boththesingleaminoacidinsert(Thr)
close to the N-terminus and a glutamate-rich hexapeptide
insert close to the C-terminus are pivotal to the bioactivity
of hGIF [6]. The CPCP motif is also key to the bioactivity;
maybe this motif is the speciﬁc binding site of hMT3 with
other biological molecules [17–19], the solvent accessibility
of the metal-thiolate cluster, which is closely associated
with the structure of the protein, and mutual accessibility
of metal-thiolate clusters with biologically sensitive small
molecules [20–23]. Moreover, domain-domain interactions
maybe play important roles in modulating the stability of
the metal-thiolate cluster and the conformation of the β-
domain, and so forth.
The earlier research showed that α-domain is very
signiﬁcant to the biological function of the protein. We
proposed that the α-domain has a stabilizing eﬀect to β-
domain in hGIF. However, the mechanism of this stabilizing
eﬀect remains unclear. In 2003, Dr. Wenhao Yu in our lab
constructed C34M and C35S mutants of monkey metal-
lothionein and discovered that the newly formed α-domain
(residue 32 to 61) was able to combine with up to fourfold
of metal ions, although the domain had only nine cysteines
[24]. Besides, the number of cysteine in the α-domain of
sheep metallothionein (sGIF), which was found in 2002,
is nine, two less than other species which contain eleven
cysteines. Hence, by comparing the primary structure of
hGIF with sGIF, we constructed an hGIF Δ33-35 mutant
(Δ33-35 mutant, the fragment of 33SCC35 in hGIF was
removed, and it contains two M3S9 clusters as same as sGIF)
and a β(MT3)-β(MT3) mutant. The biochemical properties
of the mutants were characterized by pH titration, EDTA,
and DTNB reaction, and their bioactivity toward neuron
survival and neurite extension was also examined. We found
that in hGIF Δ33-35 mutant the truncated α-domain (also
named as β -domain in this paper) contains M3S9 cluster
which is similar to the wild type hGIF β-domain, while it
exhibits the functions of α-domain with M4S11 cluster in
human growth inhibitory factor. The experimental results
showed that the stability and solvent accessibility of the
metal-thiolate cluster in the β-domain is very signiﬁcant to
the neuronal growth inhibitory activity of hGIF and also
indicated that the particular primary structure of the α-
domain of hGIF is pivotal to domain-domain interaction in
hGIF.
2. Experimental
2.1. Reagents. Fusion expression vector pGEX-4T-2,
Escherichia coli strain BL21, glutathione Sepharose 4B,
Superdex-75, and Sephadex G-25 were purchased from
Amersham Pharmacia Biotech. The (deoxy-ribonucleoside
triphosphate) dNTP, T4 DNA ligase, and restriction
enzymes, BamH I and EcoR I,w e r ep u r c h a s e df r o mN e w
England Biolabs. Pfu DNA polymerase, cell culture reagents,
isopropyl β-D-thiogalactoside (IPTG), and Triton-100
were purchased from Sangon (Shanghai, China). The
DNA gel extraction kit was purchased from Qiagen. 2,2 -
dithiodipyridine, 5,5 -dithiobis-(1-nitrobenzoic acid) (DTN
B), ethylenediamine tetraacetic acid (EDTA), and thrombin
were from Sigma (St. Louis, MO, USA). Neurobasal-A
medium and B27 serum-free supplements were purchased
from GIBCO-BRL (Gaithersburg, MD, USA). The other
reagents were of analytic grade.
2.2. Cloning, Expression, and Puriﬁcation of hMT3 and Its
Variants. Human MT3 (hMT3) cDNA was prepared from
cells by reverse transcription followed by polymerase chain
reaction (PCR). The genes of the β(MT3)-β(MT3) mutant,
the hGIF Δ33-35 mutant, and the single β-domain of hMT3
were ampliﬁed by PCR method [25]. Each segment was
digested and cloned into vector pGEX-4T-2 as a BamH
I/EcoR I fragment and veriﬁed by DNA sequencing. The
expression and puriﬁcation procedure for hMT3 and its
mutants were carried out as described in the instructions for
Glutathione-Sepharose 4B (GE healthcare life science) with
some modiﬁcations. Brieﬂy, cultures of cells (50mL) were
grown overnight in LB medium containing 100mgmL
−1
of ampicillin at 37
◦C. This start culture was diluted 100-
fold into 500mL of fresh 2·YTA, and the cells were induced
with 0.1mM IPTG when an absorbance of 0.6–0.8 at 600nm
was attained, followed by 1-hour growth before addition of
0.2mM ZnSO4. The cells were harvested at OD600 value of
2.5, which was generally reached 3-4 hours after induction.
Then, under protection of mercaptoethanol, the GST fusion
protein was separated by aﬃnity column of Glutathione
Sepharose4B,whichwaswashedbyPBSuntiltheabsorbance
at 280nm was less than 0.02. Then the fusion protein was
digested by thrombin for 14 hours at 25
◦Ci nac l e a v a g e
buﬀer (50mM Tris-HCl, 150mM NaCl, and 2.5mM CaCl2,
pH 8.0). The elute containing thrombin and recombinant
hMT3 (tagged Gly-Ser in the N-terminus) cleaved from
the fusion protein was pooled, concentrated, and further
separatedbyaSuperdex-75gelﬁltrationcolumnequilibrated
with10mMTris-HCl,50mMNaCl,pH8.0.Themaineluted
peak was concentrated, desalted, lyophilized, and stored at
−80
◦C.
2.3. Protein Characterization and Reconstitution. The apo-
form of hMT3 and its variants were generated according to
literature [26]a n df u l l yC d
2+-o rZ n
2+-loaded proteins were
prepared by reconstitution under the protection of nitrogen
[26].TheconcentrationofMTswasassessedbyreactingwith
2, 2 -dithiodipyridine in 10gL
−1 SDS, 1mM EDTA, and
12mLL
−1 acetate (pH 4.0), using ε324 = 19,800M
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[27]. The content of metal ions in each protein was analyzed
by ﬂame atomic absorption spectrophotometry (WFX-
110, BRAIC, Beijing, China). Electrospray ionization mass
spectrometry (ESI-MS) was used to measure the molecular
weights of hMT3 and its variants. Each protein was dissolved
in 1% formic acid (v/v) at a concentration of 10ngmL
−1.
The measurement was carried out on a Bruker Esquire 3000
electrospray mass spectrometer (Bruker Daltonics, Bremen,
Germany). The instrumental conditions were capillary volt,
4kV; dry gas, 5L min
−1; nebulizer gas, 15 PSI; and infusion
ﬂow rate, 3μLmin
−1.
2.4. UV-Vis and Circular Dichroid Spectra. The UV-vis
absorption spectra were scanned from 200 to 400nm on a
HP8453 UV-vis spectrophotometer (Hewlett-Packard, Palo
Alto, CA, USA) at room temperature using a 1.0 cm
quartz cuvette. CD spectra were measured in the range of
200–300nm on a Jasco J-715 spectropolarimeter at room
temperature in phosphate buﬀer (10mM Tris-HCl, 100mM
KCl, pH 8.0).
2.5. pH Titration. The spectrophotometric pH titration
was performed according to the method of Winge and
Miklossy [10]. Brieﬂy, 6-7μMC d 2+-reconstituted proteins
were dissolved in 10mM Tris-HCl, pH 8.0, containing
100mM KCl and titrated with increasing amounts of 1M
HCl. The progress of acidiﬁcation was monitored at 250nm
on the HP8453 UV spectrophotometer.
2.6. Reaction with EDTA and DTNB. The reactions of
Cd2+-reconstituted hMT3 and its mutants with EDTA were
investigated at 25
◦C according to the method of Li et al.
[28]: 9μM protein was reacted with 1.2mM EDTA in 10mM
Tris-HCl, pH 8.0, containing 100mM KCl. To avoid the
absorbance of EDTA, the reaction was monitored at 265nm
ontheHP8453UVspectrophotometerat20-seocndintervals
for 100 minutes. The reactions of Cd
2+-reconstituted hMT3
and its mutants with DTNB were studied according to the
method of Shaw et al. [29]: 3.5μMp r o t e i nw a sr e a c t e d
with 1mM DTNB in 10mM Tris-HCl, pH 8.0, containing
100mM KCl at 25
◦C. The reaction was monitored at 412nm
(ε412 = 13,600mol
−1cm−1) on an HP8453 UV spectropho-
tometer at 20-second intervals for 60 minutes.
2.7. Preparation of Rat Brain Extract. Rat brain extracts were
prepared as described previously [3]. Brieﬂy, the whole brain
from adult male Hooded Wistar rat (∼200g) was removed
and homogenized in one volume of Hanks buﬀer, followed
by centrifugation at 100×g. The supernatant was ﬁlter-
sterilized (0.22μm ﬁlter, Millipore, Billerica, MA, USA).
The total protein concentration of freshly prepared rat
brain extract was determined by the Bradford method, and
brain extracts were used immediately at a concentration of
150μgmL
−1 [30].
2.8. Culture of Cerebral Cortical Cells. Cultures of cerebral
cortical cells were prepared as described previously [30, 31]
with slight modiﬁcation. Brieﬂy, cerebral cortices of Wistar
rat fetuses (day 18) were removed and cells were dissociated
mechanically by passing coarsely minced cortical tissues
gently and repeatedly through a pipette. Tissue debris was
removedbygentlypassing throughaﬁlter.Cellswerewashed
and suspended in a speciﬁc culture medium developed
for selective neuronal growth, consisting of Neurobasal-A
medium (GIBCO), 0.1% (f/c) B-27 supplement (GIBCO),
and 0.1mM (f/c) L-glutamine (Sigma). Then the cells
were seeded on polylysine-coated 24-well culture plates at
a density of 1 × 105 cells/well. Cultures were maintained
in a 37
◦C chamber under an atmosphere of humidiﬁed
air containing 5% CO2. Four hours later, the culture
medium was replaced with fresh medium containing with
150μgmL
−1 rat brain extract and 10–20μgmL
−1 proteins.
Cultures were maintained under the same conditions for
three days. To visualize neuronal cells, cultures were ﬁxed
in 4% paraformaldehyde and then stained with trypan
blue. Finally, the neuron neurite length was determined
by measuring the distance between the end of the neurite
and the cell surface using the Leica Qwin program (Rueil
Malmaison, France) and at least 60 neurons with more than
100 neurites were recorded in each individual experiment.
3. Results and Discussion
DNA sequencing showed that all mutation genes were
successfully constructed, and the primary structure of hMT3
and its mutants were shown in Figure 1. After expression and
puriﬁcation, the yields of recombinant proteins were about
9mgL
−1 culture.SincetheseproteinswerecleavedfromGST
fusion proteins by thrombin, they had an additional Gly-Ser
dipeptide in the N-terminus. However, the existence of the
additional dipeptide does not obviously aﬀect the structure
a n dp r o p e r t i e so ft h ep r o t e i n[ 31]. Their molecular weights
were conﬁrmed by ESI-MS, and the measured molecular
weights were in good match with the theoretical values
(Table 1). According to previous studies, Cd2+ is considered
to be a useful probe of Zn
2+ binding sites in MTs [32, 33],
providing a wealth of structural information on the Zn2+-
substituted MTs. Furthermore, the Cd2+-substituted MTs
show a number of advantages over the Zn2+-substituted
MTs, including a tendency toward higher oxidation stability,
pronounced and thus easier to detect and quantify LMCT
band, as well as the use of the 111Cd or 113Cd isotopes for
NMR experiments, and so forth. Thus, Cd2+ has frequently
been used as a substitute for Zn2+ in structural studies
of hMT3 [20, 23, 34, 35]. In the present studies, Cd2+-
reconstituted MTs were adopted in both spectroscopic and
metal-binding studies, while Zn2+-reconstituted MTs were
only used in bioassays, because Cd2+-MT is cytotoxic to the
neurons in the bioassays [17]. The metal contents of hMT3
and its variants were determined by ﬂame atomic absorption
spectrophotometry and are listed in Table 1.
Figure 2(a) shows the UV-vis spectra of Cd2+-reconsti-
tuted hMT3 and its mutants, dissolved in 10mM Tris-HCl,
pH 8.0, containing 100mM KCl. All the spectra showed an
absorption shoulder at about 250nm, which is the character
of ligand-to-metal charge transfer (LMCT) of Cd-S bond
[36]. The absorption at 280nm was pretty low because4 Bioinorganic Chemistry and Applications
MDPEACPCPTGGSCTCSDSCKCEGCTCASSKK SCCPAECEKCAKDCVCKGGEGAEAEEKKCGCCQ
MDPETCPCPSGGSCTCADSCKCEGCKCTSCKKSCCSCCPAECEKCAKDCVCKGGEAAEAEAEKCSCCQ
MDPETCPCPSGGSCTCAD SCKCEGCKCTSCKKSMDPE TCPCPSGGSCTCADSCKCEGCKCTSC
MDPETCPCPSGGSCTCAD SCKCEGCKCTSCKK SCCPAECEKCAKD CVCKGGEAAEAEAEKCSCCQ
Human GIF
Sheep GIF
Δ33-35 mutant
β(MT3)-β(MT3)
Removed fragment α-domain
β-domain Linker
Figure 1: Amino acid sequence alignments of sheep MT3, human MT3, and its mutants.
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Figure 2: The UV (a) and CD (b) spectra of Cd2+-reconstituted hGIF (blue line), the Δ33-35 mutant (green line), the β(MT3)-β(MT3)
mutant (black line), and the single β-domain of hGIF (red line). All proteins are dissolved in 10mM Tris-HCl, 100 mM KCl (pH 8.0).
Table 1: Mass spectrometry analysis and metal contents of hGIF
and its mutants.
Protein Mw (calc.)
a Mw (meas.)b Metal content
hGIF 7,071 7,070.7 7 ±0.1
Δ33-35 mutant 6,778 6,778.6 6 ±0.3
β(MT3)- β(MT3) 6,741 6,743.21 6 ±0.2
Single β-domain 3,408 3,407.18 3 ±0.2
a The theoretical molecular weight.
b The measured molecular weight.
of the absence of aromatic amino acids. According to the
experiment result, the absorption intensity at 250nm is in
good line with the amount of Cd-S bond, indicating that the
measurement of metal contents is accurate.
CD spectrum is a common way to investigate the metal
center structure and protein secondary structure. In the
study of Metallothionein, CD is applied in the research of
the geometry and polypeptide folding secondary structure.
Figure 2(b) shows the CD spectra of hGIF, the 33-35
mutant, the β(MT3)-β(MT3) mutant, and the single β-
domain protein. The CD spectrum of hGIF agrees well with
reporters [20]. It is known that the two absorption peaks
((260 nm (+) and 240 nm (−)) located at the low-energy
region of Cd7-MT CD are signs of the formation of metal-
thiolate cluster, and the two peaks are very sensitive to the
variations of the structure of metal-thiolate cluster [13].
Compared to hGIF, the two peaks of the β(MT3)-β(MT3)
mutant diminished dramatically, and the wavelength is blue
shifted, making the shape of the β(MT3)-β(MT3) mutant
similar to that of the single β-domain. It is reasonable
by considering the previous research result that α-domain
contributes mainly to the CD spectrum of Cd7-MT while
β-domain has limited contribution. This is mainly because
the three metal atoms of the β-domain locate in the same
plane; therefore they are with high symmetry and contribute
to a small CD absorption. The N-terminal and C-terminal
of the β(MT3)-β(MT3) mutant both formed a three-metal
cluster and resulted in the weaker intensity of CD spectrum
absorption than that of hGIF. As for the 33-35 mutant, the
twopeakslocatedinlow-energyregionblueshiftedevidently
compared to hGIF. Besides, the Molar ellipticity of CD
spectrum of the 33-35 mutant decreases signiﬁcantly, and
the shape of CD spectrumis closer to single β-domain. Thus,
it is very likely to form two three-metal clusters, M3S9, in the
33-35 mutant [35]. However, there is clear distinction in
the shapes of CD spectra between the 33-35 mutant andBioinorganic Chemistry and Applications 5
234567
0
0.2
0.4
0.6
0.8
R
e
l
a
t
i
v
e
a
b
s
o
r
b
a
n
c
e
a
t
2
5
0
n
m
pH
Figure 3: UV absorbance at 250nm of pH titration of Cd2+-
reconstitutedhGIF(solidsquares),the33-35mutant(opencircles),
and the β(MT3)-β(MT3) mutant (solid triangles). All proteins are
dissolved in 10mM Tris-HCl, 100mM KCl, and pH 8.0.
the single β-domain, which demonstrates some discrepancy
existed in the β -domain of the 33-35 mutant and the β-
domain of hGIF. Maybe the diﬀerent distribution of the
cysteine in the peptide chain leads to the change of protein
folding patterns and the structure of metal-thiolate cluster,
eventually causing the change of CD spectrum.
In the experiment of pH titration, the concentration
of protons would increase with the decrease of pH. So,
protons would compete with thiolate ligand for binding to
Cd2+, which leads to the release of Cd2+from the Cd2+-
thiolate cluster, causing the declining of the characteristic
absorption at 250nm. Hence, the UV absorbance at 250nm
was recorded during the pH titration in order to investigate
the stability of the Cd-S clusters. According to our previous
study, the titration curve of hMT3 was not clearly divided
into two independent stages as it is diﬃcult to tell one
stage from the other in the pH titration plot. It is indicated
that there is no sharp stability diﬀerence between the two
Cd-S clusters. According to Figure 3, there is an obvious
distinction between the pH titration curves of the β(MT3)-
β(MT3) mutant and hGIF. Due to lacking in α-domain in
the β(MT3)-β(MT3) mutant, the stability of Cd3S9 in the
β(MT3)-β(MT3) mutant begins to decrease from neutral
pH, while the stability of Cd3S9 begins to decrease from
pH 5 in 33-35 mutant and hGIF. This further proves that
α-domain can stabilize the β-domain eﬀectively in hGIF.
Compared the pH titration curves of the 33-35 mutant
to the curves of hGIF, we found that the deletion of two
cysteines in α-domain did not inﬂuence the stability of the
Cd3S9 c l u s t e rt oa n yo b v i o u sd e g r e ei nh G I F .A sw ea l l
know, both the 33-35 mutant β -domain and the β(MT3)-
β(MT3) mutant β-domain contain a Cd3S9 cluster, while
there is a Cd4S11 cluster in the hGIF α-domain. Interestingly,
the stabilizing function of Cd3S9 in β -domain is more
similar to the Cd4S11 cluster in hGIF α-domain. This result
becomes reasonable when the primary structures of the β -
domain and the hGIF α-domain are considered since they
have the same primary structure except for the removed
fragment (33SCC35). Thus, we suggest that probably it is
due to the particular primary structure of the α-domain
they contain, which stabilized the β-domain through the
hydrogen bond or hydrophobic interaction, that play an
important role in the domain-domain interaction as we
described in the previous study [21].
The reaction of MTs with EDTA reﬂects competition
between the sulfhydryl group and the exogenous ligand in
the binding of metal ions and is also used to investigate the
stabilities of metal-thiolate cluster [35]. Under pseudoﬁrst-
order conditions (concentration of EDTA is 300 times that
of the MTs), this reaction for hMT3 and its mutants is
obviously biphasic, with a fast phase and a slow phase. The
observed rate constants were obtained by plotting ln (At −
A∞) versus time and are listed in Table 2. As shown in the
table, the velocity of β(MT3)-β(MT3) two-phase reaction
increased obviously, while that of the 33-35 mutant and
hGIF is similar in magnitude, which means that the stability
of the metal-thiolate cluster of the 33-35 mutant has no
considerable change compared to that of hGIF. This result
is consistent with the pH titration experiment result. Unlike
EDTA, DTNB can react with the nucleophilic sulfhydryl
groups in MTs. This reaction is closely related to the solvent
accessibility of the metal-thiolate cluster and usually is
biphasic for MTs [29]. According to Winge and coworkers,
the fast and slow phases may correspond to the reaction
of DTNB with the β-domain and the α-domain of MTs,
respectively [17] .T h eo b s e r v e dr a t ec o n s t a n t sw e r eo b t a i n e d
by plotting ln (A∞ − At) versus time and these are also listed
in Table 2. As indicated, the fast reaction rate constant of
the β(MT3)-β(MT3) mutant was almost twice that of hMT3,
showing that the solvent accessibility of the Cd3S9 cluster in
the β-domain of the β(MT3)-β(MT3) mutant was greatly
enhanced. However, the fast reaction velocity of the 33-
35 mutant with DTNB is closer to that of hGIF, as well
as the slow reaction velocity. This means that the solvent
accessibility of the two Cd3S9 clusters in the 33-35 mutant
is similar to its counterpart in hGIF. In regards with the
results of EDTA and DTNB reactions, the Cd3S9 cluster in
the β -domain of the 33-35 mutant, has the same stability
and solvent accessibility as the Cd4S11 cluster in the hGIF α-
domain.Thatmeansthestructureofmetal-thiolateclusterin
hGIF α-domain will not change dramatically after removing
two cysteines. Besides, compared to hGIF, the metal-thiolate
cluster in β(MT3)-β(MT3) mutant shows lower stability and
higher solvent accessibility. The most conspicuous diﬀerence
between the β(MT3)-β(MT3) mutant and the 33-35
mutant is that there is no particular amino acids sequence
in the β(MT3)-β( M T 3 )m u t a n ta st h a ti nh G I Fα-domain.
Thus, it once again proved that the primary structure of its
hGIF α-domain is important to the function, which is quite
in consistence with our pH titration experiment.
As mentioned above, Cd2+ recombinant protein is toxic
to nerve cells. Thus, Zn
2+-recombinant protein is adopted
to test the physiological function. The nerve grow inhibiting
function of hMT3, the β(MT3)-β(MT3) mutant, and 33-
35 mutant was tested. As shown in Figure 4, the average total
length of hMT1g-treated neurites at three days was 203 ±
8μm. hMT3 signiﬁcantly reduced the average neurite length
to 94±4μm.Theaverageneuritelengthsofβ(MT3)-β(MT3)6 Bioinorganic Chemistry and Applications
Table 2: Observed rate constants of reaction of MTs with EDTA and DTNB.
Protein Observed rate constants of reaction of MTs with EDTA Observed rate constants of reaction of MTs with DTNB
kf (×10
−4 s−1) ks (×10
−5 s−1) kf (×10
−3 s−1) ks (×10
−4 s−1)
hGIF 12.1 ±0.34 .2 ±0.22 .4 ±0.19 .1 ±0.2
33-35 12.5 ±0.23 .8 ±0.22 .5 ±0.18 .8 ±0.2
β(MT3)-β(MT3) 28.7 ±0.35 .8 ±0.34 .4 ±0.21 5 .6 ±0.2
hMT1g hGIF β(MT3)-β(MT3) Δ33-35
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Figure 4: Eﬀect of Zn2+-reconstituted hGIF, the 33-35 mutant,
and the β(MT3)-β(MT3) mutant on neurite extension in the
presence of adult rat brain extract (150μg/mL) after 3 days,
determined by the average neurite length of 60 neurons. As a
comparison, the result of hMT1g (a human MT1 isoform where
the segment is 20KCK
22) under the same conditions was also shown.
Error bars represent standard error values.
and 33-35 mutant-treated neurons were 150 ± 5a n d9 2±
3μm, respectively (the ± value represents the standard error
value). The neuronal growth inhibitory activity of hMT1g
and hMT3 well agrees with that reported previously [31, 35].
Moreover, the β(MT3)-β(MT3) mutant has apparent lower
inhibiting activity than that of hGIF. It would be much
lower, if taking the concentration of β-domain into account
that, the β(MT3)-β(MT3) mutant protein is two times more
active than that of equal molar hMT3 in the nerve growth
inhibition. However, the 33-35 mutant is similar to the
hGIF in neuronal growth inhibitory activity.
It has been reported that the neuronal growth inhibitory
activity of hMT3 mainly arises from its β-domain, while
the α-domain is not directly involved in neuronal growth
inhibitory activity [17]. However, the α-domain can aﬀect
the function of β-domain though domain-domain interac-
tions do exist in MTs [21, 37–39], and it has been proved
in our previous work [21, 37]. Taking all the experimental
results together, for hGIF and its mutants, the stability
and solvent accessibility of the metal-thiolate cluster in N-
terminal β-domain are in good line with the bioactivity of
the whole protein; so they may be very important to the
neuronal growth inhibitory activity of hMT3. Probably, α-
domain can inﬂuence the stability and solvent accessibility
of the metal-thiolate cluster in β-domain through domain-
domain interaction, eventfully eﬀecting the bioactivity of the
whole protein.
4. Conclusion
Considering the experimental result of EDTA, DTNB reac-
tion, and pH titration together with the neuronal growth
inhibitory activity, we proposed that the stability and solvent
accessibility of the metal-thiolate cluster in β-domain is
very signiﬁcant to the neuronal growth inhibitory activity
in hGIF. Comparing the β-domain of the β(MT3)-β(MT3)
mutant and the β-domain of the 33-35 mutant, these two
mutants have diﬀerent biological activities. It is precisely
because the 33-35 mutant has the β -domain which
is similar to hGIF α-domain. This further demonstrates
that α-domain stabilizes β-domain via the domain-domain
interaction in hGIF, thus to regulate the physiological
activity. Moreover, in the present study, we found that
there was an obvious diﬀerence between the 33-35 mutant
and the β(MT3)-β(MT3) in spectroscopy and biochemical
properties. The β -domain of the 33-35 mutant, which
contains M3S9 cluster, has the same metal-thiolate cluster as
the β-domain of β(MT3)-β(MT3) mutant and still reserves
the function of the M4S11 cluster of the hGIF α-domain. This
indicated that the removing of two conservative cysteines
does not lead to great changes of the metal-thiolate cluster in
the hGIF α-domain. Meanwhile, the β -domain of the 33-
35 mutant is obviously diﬀerent from the β-domain of the
β(MT3)-β(MT3) mutant in the stabilizing eﬀect, of which
the most conspicuous diﬀerence is that the β -domain of the
33-35 mutant contains the primary structure of the hGIF
α-domain. But the β-domain of β(MT3)-β(MT3) mutant
contains the primary structure of the hGIF β-domain. That
indicated that the particular primary structure of α-domain
is pivotal to domain-domain interaction in hGIF. We believe
that our results will provide a step further toward better
understanding of the relationship between the structure of
metal-thiolate cluster and the bioactivity of this group of
fascinating molecules.
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